Nörofarmakoloji
Özet
Bu metin, santral sinir sistemindeki nörotransmitterlerin sınıflandırılmasını, özelliklerini ve bu sistemde görev alan ilaçların etki mekanizmalarını incelemektedir. Antiepileptik, hipnosedatif, opioid ve santral etkili kas gevşetici ilaçların farmakolojik özellikleri, çalışma prensipleri ve yan etkileri ayrıntılı olarak ele alınmaktadır. Ayrıca nöronlar arası iletişimde rol oynayan kimyasal mekanizmalar ve klinik uygulamalardaki güncel yaklaşımlar üzerinde durulmaktadır.
This text examines the classification and properties of neurotransmitters in the central nervous system, along with the mechanisms of action for drugs acting upon this system. The pharmacological characteristics, working principles, and side effects of antiepileptic, hypnotic-sedative, opioid, and centrally acting muscle relaxant drugs are discussed in detail. Furthermore, the chemical mechanisms involved in neuronal communication and current approaches in clinical applications are emphasized.
Referanslar
R. Benjamin Free, Janet Clark, Susan Amara, and David R. Sibley. Neurotransmission in the Central Nervous System. Lawrence L. Brunton, Randa-Hilal Dandan, Björn C. Knollmann, Editors. Goodman and Gilman’s The Pharmaceutical Basis Of Therapeutics. 13. Edition. New York: Mc Grew Hill Education; 2018.p.243-266
John A. Gray. Introduction to the Pharmacology of CNS Drugs. Bertram G. Katzung, Editor. Basic and Clinical Pharmacology. 14. Edition. New York: Mc Grew Hill Education; 2018.p.367-380
Dona Lee Wong , T. C. Tai, David C. Wong-Faull et al. Epinephrine: A Short- and Long-Term Regulator of Stress and Development of Illness A Potential New Role for Epinephrine in Stress. Cell Mol Neurobiol (2012) 32:737–748
Dai-Hung Ngo, Thanh Sang Vo. An Updated Review on Pharmaceutical Properties of Gamma-Aminobutyric Acid. Molecules 2019, 24, 2678:1-23
Brian S. Meldrum. Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology. The Journal of Nutrition, Volume 130, Issue 4, April 2000, Pages 1007S–1015S
Janice C. Froehlich. Opioid Peptides. Alcohol Health Res World. 1997; 21(2): 132–136.
S.Oğuz Kayaalp, İ. Tayfun Uzbay. Santral Sinir Sistemi Farmakolojisinin Temelleri. S. Oğuz Kayaalp, Editör. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 12. Baskı. Ankara: Pelikan Yayıncılık; 2010.p.623-659
Semai Bek, Tayfun Kaşıkçı, Güray Koç, Gençer Genç, Zeki Gökçil, Zeki Odabaşı. Epilepsi Tedavisinde Klasik ve Yeni Antiepileptik İlaç Seçimi. Turk Norol Derg 2009;15:71-77
Roger J. Porter, Michael A. Rogawski. Antiseizure Drugs. Bertram G. Katzung, Editor. Basic and Clinical Pharmacology. 14. Edition. New York: Mc Grew Hill Education; 2018.p.409-440
Misty D. Smith, Cameron S. Metcalf, and Karen S. Wilcox. Pharmacotherapy of the Epilepsies. Lawrence L. Brunton, Randa-Hilal Dandan, Björn C. Knollmann, Editors. Goodman and Gilman’s The Pharmaceutical Basis Of Therapeutics. 13. Edition. New York: Mc Grew Hill Education; 2018.p.303-327
S. Oğuz Kayaalp, Turgay Dalkara. Antiepileptik İlaçlar. S. Oğuz Kayaalp, Editör. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 12. Baskı. Ankara: Pelikan Yayıncılık; 2010.p.884-901
Martin J Brodie, Patrick Kwan. Current position of phenobarbital in epilepsy and its future Epilepsia. 2012 Dec;53 Suppl 8:40-6
Ingrid Fricke-Galindo, Adrian LLerena, Helgi Jung-Cook , Marisol Lopez-Lopez. Carbamazepine adverse drug reactions. Expert Rev Clin Pharmacol. 2018 Jul;11(7):705-718
David M. Treiman. GABAergic Mechanisms in Epilepsy. Epilepsia. 2001;42 Suppl 3:8-12
Ahmed Naguy, Najah Al-Enezi. Lamotrigine Uses in Psychiatric Practice. Am J Ther. Jan/Feb 2019;26(1):e96-e102
Katherine A Lyseng-Williamson. Levetiracetam: a review of its use in epilepsy. Drugs. 2011 Mar 5;71(4):489-514
Katherine A. Lyseng-Williamson. Topiramate, A Review of its Use in the Treatment of Epilepsy. Drugs. 2007;67(15):2231-56
Wolfgang Löscher. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16(10):669-94
Cascade E, Kalali AH. Use of benzodiazepines in the treatment of anxiety. Psychiatry (Edgmont). 2008 Sep;5(9):21-22
Kelly MD, Smith A, Banks G, et al. Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands. Br J Pharmacol. 2002 Jan;135(1):248-256
Kaufmann WA, Humpel C, Alheid GF, Marksteiner J. Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res. 2003 Feb 21;964(1):91-99
Kaye AD, Gayle K, Kaye AM. Pharmacological agents in moderate and deep sedation. In: Urman RD, Kaye AD, eds. Moderate and Deep Sedation. New York, NY: Cambridge University Press; 2012:8-32
S.Oğuz Kayaalp. Hipnosedatif İlaçlar. S. Oğuz Kayaalp, Editör. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 12. Baskı. Ankara: Pelikan Yayıncılık; 2010.p.884-901
Suzana Uzun, Oliver Kozumplik, Miro Jakovljevic, Biserka Sedic. Side Effects of Treatment Benzodiazepines. Psychiatria Danubina, 2010; Vol. 22, No. 1, pp 90–93
Charles E Griffin, Adam M Kaye, Franklin Rivera Bueno, Alan D Kaye. Benzodiazepine pharmacology and central nervous system-mediated effects Ochsner J. Summer 2013;13(2):214-23
S. John Mihic, Jody Mayfield, and R. Adron Harris. Hypnotics and Sedatives. Lawrence L. Brunton, Randa-Hilal Dandan, Björn C. Knollmann, Editors. Goodman and Gilman’s The Pharmaceutical Basis Of Therapeutics. 13. Edition. New York: Mc Grew Hill Education; 2018.p.339-354
Anthony J. Trevor. Sedative-Hypnotic Drugs. Bertram G. Katzung, Editor. Basic and Clinical Pharmacology. 14. Edition. New York: Mc Grew Hill Education; 2018.p.381-395
Michael C. Smith, Barry J. Riskin. The Clinical Use of Barbiturates in Neurological Disorders. Drugs. 1991 Sep;42(3):365-78
Andrea M. Trescot, Sukdeb Datta, Marion Lee, Hans Hansen. Opioid Pharmacology. Pain Physician 2008: Opioid Special Issue: 11: S133-S153
Tony Yaksh, Mark Wallace. Opioids, Analgesia, and Pain Management. Lawrence L. Brunton, Randa-Hilal Dandan, Björn C. Knollmann, Editors. Goodman and Gilman’s The Pharmaceutical Basis Of Therapeutics. 13. Edition. New York: Mc Grew Hill Education; 2018.p.355-386
S.Oğuz Kayaalp. Santral Etkili Kas Gevşeticiler. S. Oğuz Kayaalp, Editör. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 12. Baskı. Ankara: Pelikan Yayıncılık; 2010.p.705-710
Roger Chou, Kim Peterson, Mark Helfand. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004 Aug;28(2):140-75
Ryan E. Hibbs and Alexander C. Zambon. Nicotine and Agents Acting at the Neuromuscular Junction and Autonomic Ganglia. Lawrence L. Brunton, Randa-Hilal Dandan, Björn C. Knollmann, Editors. Goodman and Gilman’s The Pharmaceutical Basis Of Therapeutics. 13. Edition. New York: Mc Grew Hill Education; 2018.p.177-190
Aydin S Köksal, Seyfettin Köklü, Levent Filik, Nurgül Şaşmaz, Burhan Şahin Phenyramidol-associated liver toxicity.Ann Pharmacother. 2003 Sep;37(9):1244-6
David D Bushart, Haoran Huang, Luke J Man, Logan M Morrison, Vikram G Shakkottai. Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1. Mov Disord . 2021 Mar;36(3):622-631
Marieke Kruidering-Hall, Lundy Campbell. Skeletal Muscle Relaxants. Bertram G. Katzung, Editor. Basic and Clinical Pharmacology. 14. Edition. New York: Mc Grew Hill Education; 2018.p.474-491
Maria Paola Mascia, Elisabetta Bachis, Nicola Obili, Elisabetta Maciocco, Giovanni Antonio Cocco, Gian Pietro Sechi, Giovanni Biggio. Thiocolchicoside inhibits the activity of various subtypes of recombinant GABA(A) receptors expressed in Xenopus laevis oocytesEur J Pharmacol. 2007 Mar 8;558(1-3):37-42
